참고문헌
- Banchereau J, Briere F, Caux C, et al (2000). Immunobiology of dendritic cells. Annu Rev Immunol, 18, 767-811. https://doi.org/10.1146/annurev.immunol.18.1.767
- Barrios K, Celis E (2012). TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers. Cancer Immunol Immunother, 61, 1307-17. https://doi.org/10.1007/s00262-012-1259-8
- Chen Z, Kamath P, Zhang S, et al (1996). Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18. Cancer Gene Ther, 3, 18-23.
- Evan G, Littlewood T (1998). A matter of life and cell death. Science, 281, 1317-22. https://doi.org/10.1126/science.281.5381.1317
- Frazer IH, Quinn M, Nicklin JL, et al (2004). Phase I study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine, 23, 172-181. https://doi.org/10.1016/j.vaccine.2004.05.013
- Koutsky LA, Harper DM (2006). Chapter 13: Current findings from prophylactic HPV vaccine trials. Vaccine, 24, 114-21. https://doi.org/10.1016/j.vaccine.2006.06.014
- Levine AJ (1997). P53, the cellular gatekeeper for growth and division. Cell, 88, 323-31. https://doi.org/10.1016/S0092-8674(00)81871-1
- Liu Z, Xu X, Hsu HC, et al (2003). CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CIIinduced arthritis. J Clin Invest, 112, 1332-41. https://doi.org/10.1172/JCI200319209
-
Lu L, Lee WC, Takayama T, et al (1999). Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-
$\beta$ , and CTLA4Ig). J Leukocyte Biol, 66, 293-6. - Matsue H, Matsue K, Walters M, et al (1999). Induction of antigen-specific immunosuppression by CD95L cDNAtransfected 'killer' dendritic cells. Nat Med, 5, 930-7. https://doi.org/10.1038/11375
- Milde-Langosch K, Riethdorf S, Loning T (2000). Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions: theoretical and practical implications. Virchows Arch, 437, 227-33. https://doi.org/10.1007/s004280000234
- Morelli AE, Thomson AW (2003). Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev, 196, 125-46. https://doi.org/10.1046/j.1600-065X.2003.00079.x
- Morita Y, Yang J, Gupta R, et al (2001). Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest, 107, 1275-84. https://doi.org/10.1172/JCI11490
- Munger K, Basile J, Duensing S, et al (2001). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20, 7888-98. https://doi.org/10.1038/sj.onc.1204860
- Parkin DM, Bray F (2006). The burden of HPV-related cancers. Vaccine, 24, 11-25.
- Steinman RM, Nussenzweig MC (2002). Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA, 99, 351-8. https://doi.org/10.1073/pnas.231606698
- Sufang Wu, Li Meng, Shixuan Wang, et al (2006). Reversal of the malignant phenotype of cervical cancer CaSki Cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA. Clin Cancer Res, 12, 2032-7. https://doi.org/10.1158/1078-0432.CCR-05-2567
- Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
- Watanabe S, Kagamu H, Yoshizawa H, et al (2003). The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J Immunol, 171, 5828-36. https://doi.org/10.4049/jimmunol.171.11.5828
- Werness BA, Levine AJ, Howley PM (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-9. https://doi.org/10.1126/science.2157286
- Wheeler CM (2007). Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol, 4, 224-35. https://doi.org/10.1038/ncponc0770
- Young A (2010). HPV vaccine acceptance among women in the Asian Pacific: a systematic review of the literature. Asian Pac J Cancer Prev, 11, 641-9.
- Zeng Q, Peng S, Monie A, et al (2011). Control of ervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents. Hum Gene Ther, 22, 809-19. https://doi.org/10.1089/hum.2010.071
- Zur Hausen H (1996). Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta, 1228, F55-78.
- zur Hausen H (2000). Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst, 92, 690-8. https://doi.org/10.1093/jnci/92.9.690
피인용 문헌
- TLR9 Expression in Uterine Cervical Lesions of Uyghur Women Correlate with Cervical Cancer Progression and Selective Silencing of Human Papillomavirus 16 E6 and E7 Oncoproteins in Vitro vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5867
- Development and Clinical Evaluation of Dendritic Cell Vaccines for HPV Related Cervical Cancer - a Feasibility Study vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5909
- Immunotherapeutic Effects of Dendritic Cells Pulsed with a Coden-optimized HPV 16 E6 and E7 Fusion Gene in Vivo and in Vitro vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3843
- Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer (Review) pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3295
- -Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma vol.2018, pp.2314-7156, 2018, https://doi.org/10.1155/2018/9832467
- Activities of stromal and immune cells in HPV-related cancers vol.37, pp.1, 2018, https://doi.org/10.1186/s13046-018-0802-7